PER 1.27% 8.0¢ percheron therapeutics limited

Ann: Positive outcomes in DMD combination therapy animal study, page-74

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 72 Posts.
    lightbulb Created with Sketch. 51
    The company needs a communication / marketing plan shake up - there are several areas that aren't well explained but I want us to shout out the answers of the following:

    - why is ANP unique to other drugs/companies in the DMD / MS / Limb-Girdle / Long Covid space?
    - why is ATL1102 unique?
    - where is the updated easy to read / visual calendar of expected events?
    - do we have the right stock broker looking after us? When was the last time they explained the company to their investors? When is the last time they purchased a share?

    Also, anyone able to access the website? Seems to be down?

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.